EASTERN COOPERATIVE ONCOLOGY GROUP

我们的计划非常适合参与临床试验。 东方合作肿瘤学小组的活动。这个 罗切斯特大学癌症中心(URCC)是一个健康和 以多医院联盟形式组织的研究机构 涉及L三级护理中心和4个全方位服务社区 医院。致力于临床和基础实验室 研究、病人护理和教育。教员们举行了初选 中心的学术任命以及一名教师 受聘于大学临床或基础科学系。 它为120万人口提供服务。我们的ECOG成员资格 已发展到包括5个额外的表演站点，涉及 外展社区医院(4个位于东北地区 国家科委和L在加拿大魁北克的卫星会员。 本经社小组支持的持续的长期目标和具体目标 申请包括：L)参与多式联运二期和 3)临床研究；2)加快癌症治疗的进展 通过增加成人患者的应计利润；3)加强基础- 科学与临床的互动；4)进一步开展癌症控制 和预防举措；5)广泛传播 通过快速数据收集和出版提供信息；6) 维持质量和及时的数据管理，7)继续 服务于本集团的行政职责。 多学科技术在日常癌症中的转移 练习设置受益的不仅仅是那些进入 研究方案，也适用于癌症患者的治疗 “标准”方法。通过经社理事会的交流、教育和 最佳治疗，我们有望提供最先进的护理， 提高我们癌症的存活率和生活质量 病人。

Our program is ideally suited to participate in the clinical trial activities of the Eastern Cooperative Oncology Group. The University of Rochester Cancer Center (URCC) is a health and research institute organized as a multihospital consortium involving l tertiary care center and 4 full-service community hospitals. It is committed to clinical and basic laboratory research, patient care, and education. The faculty hold primary academic appointments in the Center as well as a teaching appointment in a University clinical or basic science department. It serves a population of 1.2 million people. Our ECOG membership has grown to include 5 additional performance sites involving outreach community hospitals (4 located in the regional Northeast section of the country and l satellite member in Quebec, Canada. Continued long-term goals and specific aims supported by this ECOG application include: l) participation of multimodal Phase II and III clinical studies; 2) accelerate the advances of cancer therapy in adult patients through increased accrual; 3) enhance basic- science clinical interactions; 4) further develop cancer control and prevention initiatives; 5) provide wide dissemination of information through rapid data collection and publications; 6) maintenance of quality and timely data management and 7) continued service to the administrative responsibilities of the Group. The transfer of multidisciplinary technology in the daily cancer practice setting benefits not only the those patients entered onto research protocols, but also to cancer patients treated with "standard" approaches. Through ECOG communication, education, and optimal treatment, we can hopefully provide state-of-the-art care, increased survival and improved quality of life to our cancer patients.